Pulmonary Diseases and Critical Care physicians at the University of Michigan focus on pulmonary (lungs and breathing) disorders and critical illnesses (conditions such as shock, respiratory failure, and multiple organ failure). Our multidisciplinary teams treat the full scope of pulmonary issues including asthma, COPD and emphysema and cystic fibrosis.
The University of Michigan Transplant Center is the largest and most experienced lung transplant center in Michigan, and among the largest in the nation, with 20-40 lung transplants performed each year, and patient survival rate at one year at 90% – and we offer services that are not available widely, including Ambulatory ECMO (Extracorporeal Membrane Oxygenation) – an alternative to a ventilator that allows patients waiting for lung transplant to remain active and stay healthier, plus novel clinical trials available in few centers across the U.S.
The PDF links on this page link to material in the University of Michigan Lung Transplant Patient Education Guide and allow you to view and print the information on your own computer.
The University of Michigan Transplant Center is the largest and most experienced transplant center in Michigan, and among the largest in the nation, with 20-40 lungs transplants performed each year, and patient survival rate at one year at 90% – and we offer services that are not available widely, including Ambulatory ECMO (Extracorporeal Membrane Oxygenation) – an alternative to a ventilator that allows patients waiting for lung transplant to remain active and stay healthier, plus novel clinical trials available in few centers across the U.S.
The University of Michigan Health Transplant Center is the largest and most experienced transplant center in Michigan, and among the largest in the nation, with 20-40 lungs transplants performed each year, and patient survival rate at one year at 90% – and we offer services that are not available widely, including Ambulatory ECMO (Extracorporeal Membrane Oxygenation) – an alternative to a ventilator that allows patients waiting for lung transplant to remain active and stay healthier, plus novel clinical trials available in few centers across the U.S.
